Urine IP-10, on the other hand, can be a useful biomarker for detecting active LN but it still needs a standardized method of measurement, as well as prospective studies correlating with biopsy-proven active LN to establish its value. This evidence concerns the gene CXCL10 and lobular neoplasia.